Erasmus MC
Rotterdam, Netherlands
Mircea Tesileanu, MD, is a PhD candidate at the Department of Neuro-Oncology at the Erasmus Medical Cancer Center in Rotterdam, the Netherlands. His work focusses on patients with 1p/19q non-codeleted anaplastic glioma from the randomized phase 3 EORTC CATNON trial. Moreover, he investigates the relation between molecular abnormalities and the efficacy of concurrent and adjuvant temozolomide.
